Apofore is developing novel therapeutics for Type 2 diabetes based on the naturally occurring protein, Apolipoprotein A-IV (apo A-IV). The company’s approach is based on the discovery by its scientific founder Patrick Tso, PhD, at the University of Cincinnati, of apo A-IV as an important regulator of insulin secretion and glucose homeostasis. Recombinant apo A-IV, the company’s lead therapeutic, is in preclinical development. Apofore is a focused company funded by HealthCare Ventures.
| Website | https://www.apofore.com/ |
| Employees | 16 (2 on RocketReach) |
| Founded | 2013 |
| Address | 55 Cambridge Pkwy, Cambridge, Massachusetts 02142, US |
| Industry | Biotechnology Research, Drug Discovery |
Looking for a particular CanTx employee's phone or email?
2 people are employed at CanTx.
CanTx is based in Cambridge, Massachusetts.